Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Barinthus Biotherapeutics (BRNS) Short-Term Debt repayments (2022)

Barinthus Biotherapeutics' Short-Term Debt repayments history spans 1 years, with the latest figure at $159000.0 for Q1 2022.

  • For Q1 2022, Short-Term Debt repayments changed N/A year-over-year to $159000.0; the TTM value through Dec 2022 reached $159000.0, changed N/A, while the annual FY2022 figure was $159000.0, N/A changed from the prior year.
  • Short-Term Debt repayments reached $159000.0 in Q1 2022 per BRNS's latest filing.
  • In the past five years, Short-Term Debt repayments ranged from a high of $159000.0 in Q1 2022 to a low of $159000.0 in Q1 2022.